Halma plc American Depositary Receipt logo

Halma plc American Depositary Receipt (H110)

Market Open
7 Aug, 06:01
XFRA XFRA
100. 00
0
0%
- Market Cap
- P/E Ratio
0.42% Div Yield
0 Volume
0 Eps
100
Previous Close
Add Transaction
Day Range
100 100
Year Range
69 105
Want to track H110 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

H110 trading today higher at €100, an increase of 0% from yesterday's close, completing a monthly increase of 0% or €0. Over the past 12 months, H110 stock gained 31.5789%.
H110 pays dividends to its shareholders, with the most recent payment made on Feb 13, 2026. The next announced payment will be in In 2 weeks on Aug 28, 2026 for a total of €0.40452.
The last earnings report, released on Nov 19, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

H110 Chart

Halma plc American Depositary Receipt (H110) FAQ

What is the stock price today?

The current price is €100.00.

On which exchange is it traded?

Halma plc American Depositary Receipt is listed on XFRA.

What is its stock symbol?

The ticker symbol is H110.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.42%.

What is its market cap?

As of today, no market cap data is available.

Has Halma plc American Depositary Receipt ever had a stock split?

No, there has never been a stock split.

Halma plc American Depositary Receipt Profile

Industrial Conglomerates Industry
Industrials Sector
Marc Arthur Ronchetti CEO
XFRA Exchange
US40637C3088 ISIN
GB Country
9,625 Employees
10 Jul 2026 Last Dividend
- Last Split
- IPO Date

Overview

Halma plc is a diversified technology company primarily operating in the safety, health, and environmental markets. With its foundation dating back to 1894, it has grown to deliver a wide array of technology solutions globally. The company navigates through its mission with a clear focus on three core segments: Safety, Environmental & Analysis, and Medical. Each segment caters to a specific set of needs, from protecting people and assets to ensuring environmental sustainability and advancing health care. Headquartered in Amersham, the United Kingdom, Halma demonstrates a commitment to innovation, life protection, and improving the quality of life through its numerous subsidiaries spread across different markets.

Products and Services

  • Safety Segment

    This segment contributes to a safer world through an array of technologies, including fire detection systems, specialist fire suppression, elevator safety, and explosion protection. Notable products include security sensors, people and vehicle flow technologies, and specialized interlocks for controlling critical processes safely. Markets served include fire suppression, elevator safety, industrial access control, and more, emphasizing Halma’s commitment to protecting assets and ensuring industrial safety.

  • Environmental & Analysis Segment

    Halma's focus on environmental sustainability is evident in its Environmental & Analysis segment, offering products such as optical, optoelectronic, and spectral imaging systems. Additionally, it provides technologies for monitoring water, air, and gases alongside instruments for detecting hazardous gases and analyzing air quality. Systems for water analysis and treatment also play a crucial role, serving essential markets like optical analysis, environmental monitoring, and gas detection, thereby supporting global efforts in environmental conservation and safety.

  • Medical Segment

    This segment is dedicated to advancing healthcare through a variety of technologies and solutions. It includes critical fluidic components for medical diagnostics, laboratory devices, and systems that assist in patient health understanding. Halma also offers technologies to facilitate in-vitro diagnostic systems, life-science research, and therapeutic solutions across clinical specialties. Serving the life sciences, health assessment, and therapeutic solutions market, this segment showcases Halma’s dedication to enhancing healthcare outcomes and enabling discoveries in medicine.

Contact Information

Address: Misbourne Court
Phone: 44 1494 721111